Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

• Y Chen,
• P Jobanputra,
• P Barton,
• S Bryan,
• A Fry-Smith,
• G Harris,
• R Taylor

Affiliations

Y Chen

Department of Public Health and Epidemiology, University of Birmingham, UK

P Jobanputra

P Barton

S Bryan

A Fry-Smith

G Harris

R Taylor